Perillartine protects against metabolic associated fatty liver in high-fat diet-induced obese mice
Yang Xiao, Lianggui Xiao, Mingming Li, Songsong Liu, Yuwei Wang, Liang Huang, Siqi Liu, Tianyu Jiang, Lei Zhou, Yixing Li
Abstract
, perillartine reduced body weight gain and the fat rate, improved glucose metabolism and energy balance, and altered the gut microbial composition in mice given a high-fat diet. In addition, RORγ was identified as a possible target of perillartine through pharmacophore screening. Functional studies revealed that the overexpression of RORγ blocked the effects of perillartine, suggesting that it reduced lipid accumulation and regulated glucose metabolism by inhibiting the transcriptional activity of RORγ. Our results provide new information on a natural product inhibitor for RORγ and reveal that perillartine is a new candidate for the treatment of obesity and metabolic associated fatty liver disease.